InvestorsHub Logo
icon url

jdheart101

02/12/20 9:28 PM

#264505 RE: sentiment_stocks #264504

Ask that question if they have a q and a and get her to say it publicly if it doesn’t come up during the conference, it would be nice
icon url

photonic5

02/12/20 9:28 PM

#264506 RE: sentiment_stocks #264504

Thanks Senti!! That’s great information. Tell Dr. Liau we’re rooting for her vaccine and her patients.
icon url

aperture007

02/12/20 9:29 PM

#264507 RE: sentiment_stocks #264504

HI Sent,
Greatly appreaciate you taking the time and effort to go to this meeting. I'll be interested in UCLA's team demeanor/expressions if anything remotely comes up related to NWBO'S PIII DVAX-L trial. Enjoy the meeting and safe travels.
icon url

ATLnsider

02/12/20 9:30 PM

#264508 RE: sentiment_stocks #264504

Thank you for the update, especially the confirmation from Dr. Liau that non-branded DCVax-L is being used in combination with non-branded Keytruda (Pembrolizumab) in the Phase 1 combo trial.
icon url

Dr Bala

02/12/20 9:46 PM

#264509 RE: sentiment_stocks #264504

Thanks for the info, Senti. Please update us on the talk when able.
icon url

Ultraz2

02/12/20 10:27 PM

#264511 RE: sentiment_stocks #264504

So no money, no more trials, the company is essentially worthless with a failed trial imho...
icon url

BlueJordan

02/12/20 10:35 PM

#264513 RE: sentiment_stocks #264504

Senti, thank you so much for the live inputs and your updates. It is much much appreciated.
icon url

Kam8

02/12/20 11:40 PM

#264527 RE: sentiment_stocks #264504

Thanks alot the latest news.
icon url

vator

02/13/20 4:23 AM

#264543 RE: sentiment_stocks #264504

Good information.
icon url

Know-Fear

02/13/20 4:40 AM

#264545 RE: sentiment_stocks #264504

Good stuff, thanks.
icon url

longfellow95

02/13/20 10:24 AM

#264585 RE: sentiment_stocks #264504

Hi Senti.
Thanks for instant feedback from your conversation with LL.
It's gratifying to know that it is (to all or at least most intents and purposes) DCVax-L being used in the trial.
I take her comments to mean that the autologous DC vaccine being used is identical in formulation and production process to DCVax-L (even if it is produced at at UCLA).
And absolutely appropriate to preface the conversation by declaring your investor status.
I guess she was effectively pointing out that the terms of the trial agreement also preclude the proprietary name Keytruda being used. But no doubt has been expressed here about it being anything other than pembro!

It has to be said that LL's comments don't entirely jibe with the reported remarks of Dr Prins.
But this is confirmation enough for me that this is not a different Dendritic Cell Tumor Cell Lysate Vaccine.
icon url

biosectinvestor

02/13/20 11:33 AM

#264619 RE: sentiment_stocks #264504

Exactly what I had suggested was likely the situation when this whole imbroglio erupted with various critics.

Thank you Senti for going there and confirming the details.
icon url

Lykiri

02/13/20 12:23 PM

#264629 RE: sentiment_stocks #264504

Sentiment,

Thank you!

Julia Post Guenther

Honored to have hosted UCLA, Dr. Linda Liau and members of her staff who traveled down to talk to us about the advances in neurosurgery. So grateful


https://www.facebook.com/photo.php?fbid=10221078017250630&set=pcb.10221078018690666&type=3&theater
https://www.facebook.com/photo.php?fbid=10221080788239903&set=pcb.10221078018690666&type=3&theater
icon url

Idunno

02/13/20 6:42 PM

#264715 RE: sentiment_stocks #264504

Thanks, Senti, for all. Best.
icon url

hyperopia

02/14/20 12:09 AM

#264753 RE: sentiment_stocks #264504

senti, I'm envious of your meeting. Thank you for sharing this information (and follow-up) with the board. You are awesome!
icon url

abeta

02/14/20 12:34 AM

#264754 RE: sentiment_stocks #264504

WOW

Thanks

regards
icon url

dude409

02/14/20 6:44 AM

#264767 RE: sentiment_stocks #264504

senti... Thank you for your efforts and sharing with us. HAPPY VALENTINE.
icon url

eagle8

02/14/20 8:43 AM

#264775 RE: sentiment_stocks #264504


Thank you so much sentiment.

Best to you.